Skip to main content
رجوع
Watch Compare

Context Therapeutics Inc.

جودة البيانات: 83%
CNTX
Nasdaq Manufacturing Chemicals
KWD 2.62
▼ KWD 0.02 (-0.76%)
القيمة السوقية: 240.72 M
السعر
KWD 2.62
القيمة السوقية
240.72 M
نطاق اليوم
KWD 2.59 — KWD 2.83
نطاق 52 أسبوعًا
KWD 0.49 — KWD 3.62
حجم التداول
440,294
فتح KWD 2.65
متوسط 50 يوم / 200 يوم
KWD 2.57
2.01% above
متوسط 50 يوم / 200 يوم
KWD 1.41
85.76% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -26.42 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-46.40%
أعلى من متوسط القطاع (-53.47%)
ROIC-40.27%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio13.10
Interest CoverageN/A

التقييم

PE (TTM)
-6.66
أقل من متوسط القطاع (-1.47)
P/B Ratio3.29
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -6.7 -1.5
P/B 3.3 1.6
ROE % -46.4 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -36.12 M
ROE -46.40% ROA -43.42%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -26.42 M
ROIC -40.27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13.10
Interest Coverage N/A Asset Turnover N/A
Working Capital 73.02 M Tangible Book Value 73.17 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.66 Forward P/E N/A
P/B Ratio 3.29 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.97%
Market Cap 240.72 M Enterprise Value 163.79 M
Per Share
EPS (Diluted TTM) -0.38 Revenue / Share N/A
FCF / Share -0.29 OCF / Share -0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 73.14%
SBC-Adj. FCF -27.64 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -36.12 M -26.73 M -23.96 M -14.84 M -10.46 M
EPS (Diluted) -0.38 -0.46 -1.50 -0.93 -3.69
Gross Profit — — — — —
Operating Income -39.70 M -29.92 M -25.07 M -15.38 M -10.53 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 16,251.0 10,881.0 12,044.0 9,268.0 —
Interest Expense — — 1.16 M 547,268.0 64,240.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 68.49 M 98.13 M 16.06 M 37.97 M 51.31 M
Total Liabilities 8.02 M 2.86 M 4.19 M 3.21 M 3.03 M
Shareholders' Equity 60.47 M 95.27 M 11.87 M 34.76 M 48.27 M
Total Debt — — — — —
Cash & Equivalents 66.00 M 94.43 M 14.45 M 35.50 M 49.64 M
Current Assets 68.35 M 97.90 M 16.05 M 37.85 M 51.26 M
Current Liabilities 8.02 M 2.75 M 4.19 M 3.21 M 3.03 M